Related Experiment Video
Updated: Sep 11, 2025
08:45
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
13.5K
In the wake of the Scandinavian Simvastatin Survival Study trial
1Department of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki.
Current Opinion in Lipidology
|August 13, 2025
Summary
Statins, like simvastatin, significantly reduce cardiovascular events and mortality. Long-term use and accessibility are key to maximizing the benefits of cholesterol-lowering therapy for atherosclerotic vascular disease prevention.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Public Health
Background:
- The 4S trial revolutionized cardiovascular disease treatment by demonstrating simvastatin's efficacy in reducing atherosclerotic vascular disease (ASCVD) events and all-cause mortality.
- Over 30 years, statins have become well-tolerated, effective therapies, driving innovation in dyslipidemia management.
Purpose of the Study:
- To review current knowledge on statins, focusing on vascular and nonvascular benefits, adverse effects, and adherence.
- To discuss the evolving treatment paradigms for cholesterol lowering, emphasizing long-term LDL reduction for ASCVD prevention.
Main Methods:
- Literature review of studies following the 4S trial.
- Analysis of data on statin efficacy, safety, and patient adherence.
Main Results:
- Statins offer significant vascular and nonvascular benefits, with a trend towards 'the lower the better' for LDL cholesterol.
- Long-term statin therapy is increasingly recognized for its potential to reduce lifetime LDL burden and enhance ASCVD prevention.
- New treatments are being developed to complement statins in managing atherosclerotic lipoproteins and residual risk.
Conclusions:
- Generic statins are affordable, well-tolerated, and can substantially reduce the global burden of atherosclerotic vascular disease.
- Improving accessibility and adherence to statin therapy are crucial for realizing their full public health potential.
Related Concept Videos
01:21Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
01:15Assumptions of Survival Analysis
197
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
197
01:20Comparing the Survival Analysis of Two or More Groups
286
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
286
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
01:30Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
01:20Actuarial Approach
135
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
135